LOGIN  |  REGISTER
Assertio

BUY $ASRT

Buy $ASRT on TDAmeritrade

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Assertio to Participate in the 2023 SVB Securities Global Biopharma Conference

February 08, 2023 | Last Trade: US$0.96 0.03 -3.10

LAKE FOREST, Ill., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert, CEO, and Paul Schwichtenberg, CFO, will host investor meetings February 15, 2023 as part of the SVB Securities Global Biopharma Conference, taking place virtually.

For more information about scheduling a one-on-one meeting with management, please contact your SVB Securities representative or Matt Kreps, Investor Relations for Assertio Holdings, at This email address is being protected from spambots. You need JavaScript enabled to view it..

About Assertio

Assertio Holdings, Inc. is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. For more information regarding Assertio Holdings, go to: https://www.assertiotx.com/.

Investor Contact:
Matt Kreps
Managing Director
Darrow Associates
Austin, TX
M: 214-597-8200
This email address is being protected from spambots. You need JavaScript enabled to view it.

BUY $ASRT

Buy $ASRT on TDAmeritrade

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Stock Quote

BUY $ASRT

Buy $ASRT on TDAmeritrade

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...

CLICK TO LEARN MORE
Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB